Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7259734 | 0.82 | LMNA (0.41) | KDM4ENPC1RAB9AGLAMAPT | |
| SCHEMBL25292308 | 0.81 | CYP1A2 (0.41) | KDM4ENPC1RAB9AMAPTTDP1 | |
| SCHEMBL6634795 | 0.80 | MEN1 (0.33) | KDM4ENPC1RAB9AGLAMAPT | |
| SCHEMBL15453282 | 0.79 | KDM4E (0.39) | KDM4EGLAL3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL25295105 | 0.76 | CYP2A6 (0.42) | NPC1RAB9ASMN1; SMN2LMNACES2 | |
| SCHEMBL25291740 | 0.76 | CYP1A2 (0.44) | KDM4EGLAL3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL20395961 | 0.76 | CYP1A2 (0.38) | KDM4EL3MBTL1LMNAALDH1A1CYP1A2 | |
| SCHEMBL21767983 | 0.72 | KDM4E (0.35) | KDM4ENPC1RAB9AGLAMAPT | |
| SCHEMBL17063458 | 0.72 | NPC1 (0.39) | KDM4ENPC1RAB9AMAPTMAPK1 | |
| SCHEMBL30775092 | 0.71 | MEN1 (0.39) | KDM4ENPC1RAB9AGLAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10096784-B2 | Compound for organic optoelectric device, composition for organic optoelectric device and organic optoelectric device and display device | SAMSUNG SDI CO., LTD. (KR) | 2018-10-09 | — | — | US | disclosed |
| US-20180083202-A1 | COMPOUND FOR ORGANIC OPTOELECTRIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
| EP-0664311-B1 | Coloured polymer composition | DSM NV (NL) | 2001-09-26 | — | — | EP | disclosed |
| US-5674948-A | MASKING GROUPS IN POLYMER THAT ARE REACTIVE WITH RESPECT TO COLORANT; HEAT RESISTANCE; BRIGHTNESS | DSM N.V. (NL) | 1997-10-07 | — | — | US | disclosed |
| EP-0664311-A1 | Coloured polymer composition | DSM N.V. (NL) | 1995-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10096784-B2 | Compound for organic optoelectric device, composition for organic optoelectric device and organic optoelectric device and display device | OXER1, OCIAD1, OR10J3 | KDM4E 3867/4885NPC1 1770/4885RAB9A 3507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.